Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 252

    1.

    All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.

    Diabetes. 2009 Jan;58(1):146-55. Epub 2008 Nov 4.PMID: 18984738 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

    Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

    Diabetes. 1996 Oct;45(10):1350-7.PMID: 8826970 [PubMed - indexed for MEDLINE]Related articles

    3.

    A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity.

    Qin HY, Mukherjee R, Lee-Chan E, Ewen C, Bleackley RC, Singh B.

    Int Immunol. 2006 Jul;18(7):1001-15. Epub 2006 May 4.PMID: 16675487 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Taking a daily vitamin to prevent type 1 diabetes?

    Wasserfall C, Atkinson MA.

    Diabetes. 2009 Jan;58(1):24-5. No abstract available. PMID: 19114727 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

    Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA.

    Immunity. 2008 May;28(5):687-97. Epub 2008 May 8.PMID: 18468463 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

    Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E.

    Biochem Biophys Res Commun. 2003 May 2;304(2):378-84.PMID: 12711326 [PubMed - indexed for MEDLINE]Related articles

    7.

    CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.

    Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST.

    Diabetes. 2009 Jul;58(7):1568-77. Epub 2009 Mar 31.PMID: 19336675 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    9.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    11.

    Interferon-tau inhibits the development of diabetes in NOD mice.

    Sobel DO, Ahvazi B, Amjad F, Mitnaul L, Pontzer C.

    Autoimmunity. 2008 Nov;41(7):543-53.PMID: 18608174 [PubMed - indexed for MEDLINE]Related articles

    12.

    Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

    Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

    Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.PMID: 17570208 [PubMed - indexed for MEDLINE]Related articles

    13.

    Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.

    Yang CH, Tian L, Ling GS, Trendell-Smith NJ, Ma L, Lo CK, Stott DI, Liew FY, Huang FP.

    Eur J Immunol. 2008 Jun;38(6):1664-76. Erratum in: Eur J Immunol. 2008 Jul;38(7):2046. PMID: 18465774 [PubMed - indexed for MEDLINE]Related articles

    15.

    Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.

    Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.

    Cell Res. 2007 Jul;17(7):627-37.PMID: 17563757 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells.

    Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, Bonifacio E, Roncarolo MG.

    Diabetes. 2006 Jun;55(6):1571-80.PMID: 16731819 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses.

    Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, Grigg ME, Berzofsky JA, Belkaid Y.

    Immunity. 2008 Oct 17;29(4):637-49. Epub 2008 Oct 2.PMID: 18835196 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.

    Peterson JD, Haskins K.

    Diabetes. 1996 Mar;45(3):328-36.PMID: 8593938 [PubMed - indexed for MEDLINE]Related articles

    19.

    alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

    Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG.

    J Exp Med. 1998 Apr 6;187(7):1047-56.PMID: 9529321 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.

    Ablamunits V, Elias D, Cohen IR.

    Clin Exp Immunol. 1999 Feb;115(2):260-7.PMID: 9933451 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data